How and Where to Buy Rifaximin Online: A Complete Guide
Learn how to safely buy Rifaximin (Xifaxan) online. Compare U.S. and Canadian pharmacies, find generic options, and get prescriptions via telehealth to save money.
read more
Category: Pharmacy - Page 2
Strategies to Reduce Costs for Specialty Medications and Injectables
Learn actionable strategies to manage rising costs of specialty medications and injectables. Discover how formularies, biosimilars, and network optimization can save millions.
read more
Fasted vs Fed State Testing: Why Both Conditions Matter for Health and Medications
Fasted and fed state testing reveal how food changes drug absorption and exercise performance. Both conditions matter for accurate dosing and effective training-here's why.
read more
Pharmacist Counseling Scripts: Training Materials for Generic Patient Talks
Pharmacist counseling scripts ensure patients understand their medications by combining standardized guidance with personalized communication. Rooted in OBRA '90 and ASHP guidelines, these tools improve adherence, reduce errors, and save lives-when used flexibly, not robotically.
read more
Future Role of Authorized Generics: Market Outlook
Authorized generics let brand manufacturers stay competitive after patent expiry by selling their own drugs under generic labels. With new FDA policies and rising biosimilar use, their role is shifting from market control to transparent competition.
read more
Bioequivalence of Combination Products: Special Testing Challenges
Bioequivalence testing for combination products-like dual-drug pills, topical creams, and inhalers-is far more complex than for single drugs. Regulatory hurdles, inconsistent methods, and high costs are delaying affordable generics. Here's how science and regulation are trying to catch up.
read more
How to Identify Look-Alike Names on Prescription Labels
Learn how to spot dangerous look-alike drug names on prescription labels using tall man lettering, barcode scanning, and simple verification steps to prevent medication errors that can harm patients.
read more
180-Day Exclusivity in Generic Drug Market Entry: How Patent Challenges Shape Drug Prices
The 180-day exclusivity rule under the Hatch-Waxman Act rewards the first generic drug company to challenge a patent-but often delays market entry for years, keeping prices high. Here's how it works and why it matters for patients and drug access.
read more
Managing Different Doses in Combination Products: A Practical Guide to Therapeutic Equivalence
Managing therapeutic equivalence in combination products requires precise dose matching and awareness of formulation differences. Learn how FDA ratings, NTI drugs, and inactive ingredients impact substitution safety.
read more
Therapeutic Equivalence: Are Authorized Generics Really the Same as Brand Drugs?
Authorized generics are identical to brand-name drugs in every way except the label. Learn how they compare to regular generics, why they're trusted by the FDA, and when they're the best choice for your health.
read more
The 80-125% Rule: How Bioequivalence Confidence Intervals Ensure Generic Drugs Work Like Brand Names
The 80-125% rule ensures generic drugs work like brand names by measuring how well your body absorbs them. It's not about ingredient amounts - it's about pharmacokinetics and confidence intervals. Learn how regulators use this standard to guarantee safety and savings.
read more
Bioequivalence Studies and Special Populations: Age and Sex Requirements Explained
Bioequivalence studies must now account for age and sex differences to ensure generic drugs work safely for all patients. Learn how FDA, EMA, and other agencies are changing requirements to reflect real-world use.
read more